Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
- Wyden Statement on CBO Analysis of Supercharged Unemployment Benefits
- Bipartisan House and Senate Committee Leaders Urge HHS to Disperse COVID-19 Relief Funds to Medicaid Providers
- Wyden Statement on Trump and FDA Polluting National Drug Stockpile, COVID-19's Outsized Impact on African Americans
- Wyden Statement on TIGTA Report
- WYDEN: McConnell Comments Show Urgent Need for Triggers for Unemployment Benefits